How a single inversion. of configuration leads to a reversal of the binding mode:: Proposal of a novel arrangement of CCK2 ligands in their receptor, and contribution to the development of peptidomimetic or non-peptide CCK2 ligands

被引:8
作者
Bellier, B [1 ]
Garbay, C [1 ]
机构
[1] CNRS, Fac Pharm,Lab Pharmochim Mol & Struct, INSERM,UFR Sci Pharm & Biol, FRE 2463,U266,Dept Pharmacoch Mol & Struc, F-75270 Paris 06, France
关键词
cholecystokinin; CCK2; binding mode; peptidomimetics;
D O I
10.1016/S0223-5234(03)00112-0
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The implication of CCK2 receptors in crucial physiological functions has driven the search for synthetic ligands of this receptor. A notable rationale starting from CCK-4 (minimal endogenous CCK2 agonist), the 'dipeptoid' strategy, led to potent CCK2 antagonists exemplified by CI-988. However, careful examination of the literature enlightened several incompatibilities between the proposed recognition mode of the receptor by such compounds (or peptide analogues) and experimental data. Thus, we hypothesised that CCK2 'dipeptoid' antagonists bind the receptor in a mode opposite to that previously suggested. The reexamination of numerous published data, supported by the characterisation of new 'hybrid' compounds, brought out strong evidence that this 'reverse' mode truly characterises CCK2 'dipeptoid' antagonists. These findings renew the perspectives of further chemical development of CCK2 ligands, e.g. non-peptidic agonists. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
引用
收藏
页码:671 / 686
页数:16
相关论文
共 55 条
  • [1] AMBLARD M, 1991, P 12 AM PEPT S, P474
  • [2] Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity .1. Optimization of the agonist ''Trigger''
    Aquino, CJ
    Armour, DR
    Berman, JM
    Birkemo, LS
    Carr, RAE
    Croom, DK
    Dezube, M
    Dougherty, RW
    Ervin, GN
    Grizzle, MK
    Head, JE
    Hirst, GC
    James, MK
    Johnson, MF
    Miller, LJ
    Queen, KL
    Rimele, TJ
    Smith, DN
    Sugg, EE
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (02) : 562 - 569
  • [3] Synthesis and biological properties of new constrained CCK-B antagonists: Discrimination of two affinity states of the CCK-B receptor on transfected CHO cells
    Bellier, B
    McCortTranchepain, I
    Ducos, B
    Danascimento, S
    Meudal, H
    Noble, F
    Garbay, C
    Roques, BP
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (24) : 3947 - 3956
  • [4] Replacement of glycine with dicarbonyl and related moieties in analogues of the C-terminal pentapeptide of cholecystokinin:: CCK2 agonists displaying a novel binding mode
    Bellier, B
    Million, ME
    DaNascimento, S
    Meudal, H
    Kellou, S
    Maigret, B
    Garbay, C
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (20) : 3614 - 3623
  • [5] BELLIER B, 2000, THESIS U PARIS 5
  • [6] Side-chain-modified sulfonic analogues of aspartic and glutamic acids:: Synthesis, protection, and incorporation into peptides
    Bischoff, L
    David, C
    Roques, BP
    Fournié-Zaluski, MC
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1999, 64 (04) : 1420 - 1423
  • [7] Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor
    Blommaert, AGS
    Dhotel, H
    Ducos, B
    Durieux, C
    Goudreau, N
    Bado, A
    Garbay, C
    Rogues, BP
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (05) : 647 - 658
  • [8] CHOLECYSTOKININ PEPTIDOMIMETICS AS SELECTIVE CCK-B ANTAGONISTS - DESIGN, SYNTHESIS, AND IN-VITRO AND IN-VIVO BIOCHEMICAL-PROPERTIES
    BLOMMAERT, AGS
    WENG, JH
    DORVILLE, A
    MCCORT, I
    DUCOS, B
    DURIEUX, C
    ROQUES, BP
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (20) : 2868 - 2877
  • [9] CHOLECYSTOKININ (PANCREOZYMIN) .5. HORMONALLY ACTIVE DESAMINO DERIVATIVE OF TYR(SO3H)-MET-GLY-TRP-MET-ASP-PHE-NH2
    BODANSZKY, M
    MARTINEZ, J
    WALKER, M
    GARDNER, JD
    MUTT, V
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1980, 23 (01) : 82 - 85
  • [10] RATIONALLY DESIGNED DIPEPTOID ANALOGS OF CHOLECYSTOKININ (CCK) - C-TERMINAL STRUCTURE-ACTIVITY-RELATIONSHIPS OF ALPHA-METHYL TRYPTOPHAN DERIVATIVES
    BODEN, PR
    EDEN, JM
    HIGGINBOTTOM, M
    HILL, DR
    HORWELL, DC
    HUNTER, JC
    MARTIN, K
    PRITCHARD, MC
    RICHARDSON, RS
    ROBERTS, E
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1993, 28 (01) : 47 - 61